English

IXION BIOTECHNOLOGY INC

EDGAR

Filing (10QSB) · filed 2002-08-14

24 filing records in this dataset, filed from 1998-03-31 to 2002-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

-5.38 thousand USD

2001-12-31 · USD

Exact inputs and evidence

Revenue: 231740 USD Source
Revenue: 237115 USD Source

Net margin

14,364.41%

2001-12-31 · %

Exact inputs and evidence

Net Income: -2987502 USD Source
Net Income: -2215415 USD Source
Revenue: 231740 USD Source
Revenue: 237115 USD Source

Cash and cash equivalents: 961 thousand USD 2001-12-31 Source
Exact value

961310 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-08-14.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2001-12-31
operating income: No compatible figures in this window
Net income: 6 of 11 periods available· newest 2001-12-31
Operating cash flow: 6 of 11 periods available· newest 2001-12-31
Capital expenditure: 6 of 11 periods available· newest 2001-12-31
Total assets: 3 of 11 periods available· newest 2001-12-31
Total liabilities: 5 of 11 periods available· newest 2001-12-31
Current assets: 5 of 11 periods available· newest 2001-12-31
Current liabilities: 5 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-42.6%

Prior period

USD 403,782

2000-01-01 – 2000-12-31
Current period

USD 231,740

2001-01-01 – 2001-12-31

Exact inputs and evidence

231740 − 403782 = -172042 USD

403782 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
231740 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Year-over-year change in Revenue: -172042 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 231740 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2263 Input fundies:Revenue: 403782 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2263
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.54 million

Prior period

−USD 1.45 million

2000-01-01 – 2000-12-31
Current period

−USD 2.99 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-2987502 − -1447347 = -1540155 USD

-1447347 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-2987502 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Year-over-year change in Net income: -1540155 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2987502 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2392 Input fundies:NetIncome: -1447347 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2392
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.38 million

Prior period

−USD 1.13 million

2000-01-01 – 2000-12-31
Current period

−USD 2.51 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-2506042 − -1125566 = -1380476 USD

-1125566 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-2506042 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Year-over-year change in Operating cash flow: -1380476 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2506042 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2410 Input fundies:OperatingCashFlow: -1125566 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2410
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-45.2%

Prior period

USD 246,430

2000-01-01 – 2000-12-31
Current period

USD 135,018

2001-01-01 – 2001-12-31

Exact inputs and evidence

135018 − 246430 = -111412 USD

246430 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
135018 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Year-over-year change in Capital expenditure: -111412 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 135018 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2414 Input fundies:CapitalExpenditure: 246430 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2414
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 231,740 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 2.99 million −1,289% of revenue

Cash

Operating cash flow −USD 2.51 million −1,081% of revenue
Capital expenditure USD 135,018 58% of revenue
Free cash flow Derived −USD 2.64 million −1,140% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Not shown: operating income or net income is not reported.
2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	171205	Unavailable	Unavailable	Unavailable	-553639	-178017 Derived	Source 1996-01-01 – 1996-12-31: 171205 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -553639 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -164024 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 13993 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	221452	Unavailable	Unavailable	Unavailable	-781954	-494208 Derived	Source 1997-01-01 – 1997-12-31: 221452 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -781954 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -488451 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 5757 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	3722	Unavailable	Unavailable	Unavailable	-914239	-466644 Derived	Source 1998-01-01 – 1998-12-31: 3722 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -914239 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -454247 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 12397 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	102636	Unavailable	Unavailable	Unavailable	-1125790	-631418 Derived	Source 1999-01-01 – 1999-12-31: 102636 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -1125790 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -550241 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 81177 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	403782	Unavailable	Unavailable	Unavailable	-1447347	-1371996 Derived	Source 2000-01-01 – 2000-12-31: 403782 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -1447347 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -1125566 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 246430 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	231740	Unavailable	Unavailable	Unavailable	-2987502	-2641060 Derived	Source 2001-01-01 – 2001-12-31: 231740 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -2987502 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -2506042 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 135018 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 231.7K 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	171205	Revenue: 171205 Open source
19971997-12-31	Revenue	221452	Revenue: 221452 Open source
19981998-12-31	Revenue	3722	Revenue: 3722 Open source
19991999-12-31	Revenue	102636	Revenue: 102636 Open source
20002000-12-31	Revenue	403782	Revenue: 403782 Open source
20012001-12-31	Revenue	231740	Revenue: 231740 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-42.6% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 171205 Open source
19971997-12-31	Year over year	29.3%	Revenue: 221452 Open source Revenue: 171205 Open source
19981998-12-31	Year over year	-98.3%	Revenue: 3722 Open source Revenue: 221452 Open source
19991999-12-31	Year over year	2,657.5%	Revenue: 102636 Open source Revenue: 3722 Open source
20002000-12-31	Year over year	293.4%	Revenue: 403782 Open source Revenue: 102636 Open source
20012001-12-31	Year over year	-42.6%	Revenue: 231740 Open source Revenue: 403782 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -1,289.2% 2001

Free cash flow margin -1,139.7% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Operating margin	Not reported	Revenue: 171205 Open source
1997-12-31	Operating margin	Not reported	Revenue: 221452 Open source
1998-12-31	Operating margin	Not reported	Revenue: 3722 Open source
1999-12-31	Operating margin	Not reported	Revenue: 102636 Open source
2000-12-31	Operating margin	Not reported	Revenue: 403782 Open source
2001-12-31	Operating margin	Not reported	Revenue: 231740 Open source
19961996-12-31	Net margin	-323.4%	Net Income: -553639 Open source Revenue: 171205 Open source
19971997-12-31	Net margin	-353.1%	Net Income: -781954 Open source Revenue: 221452 Open source
19981998-12-31	Net margin	-24,563.1%	Net Income: -914239 Open source Revenue: 3722 Open source
19991999-12-31	Net margin	-1,096.9%	Net Income: -1125790 Open source Revenue: 102636 Open source
20002000-12-31	Net margin	-358.4%	Net Income: -1447347 Open source Revenue: 403782 Open source
20012001-12-31	Net margin	-1,289.2%	Net Income: -2987502 Open source Revenue: 231740 Open source
19961996-12-31	Free cash flow margin	-104%	Revenue: 171205 Open source Operating Cash Flow: -164024 Open source Capital Expenditure: 13993 Open source
19971997-12-31	Free cash flow margin	-223.2%	Revenue: 221452 Open source Operating Cash Flow: -488451 Open source Capital Expenditure: 5757 Open source
19981998-12-31	Free cash flow margin	-12,537.5%	Revenue: 3722 Open source Operating Cash Flow: -454247 Open source Capital Expenditure: 12397 Open source
19991999-12-31	Free cash flow margin	-615.2%	Revenue: 102636 Open source Operating Cash Flow: -550241 Open source Capital Expenditure: 81177 Open source
20002000-12-31	Free cash flow margin	-339.8%	Revenue: 403782 Open source Operating Cash Flow: -1125566 Open source Capital Expenditure: 246430 Open source
20012001-12-31	Free cash flow margin	-1,139.7%	Revenue: 231740 Open source Operating Cash Flow: -2506042 Open source Capital Expenditure: 135018 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.5M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	-164024	Operating Cash Flow: -164024 Open source
19971997-12-31	Operating cash flow	-488451	Operating Cash Flow: -488451 Open source
19981998-12-31	Operating cash flow	-454247	Operating Cash Flow: -454247 Open source
19991999-12-31	Operating cash flow	-550241	Operating Cash Flow: -550241 Open source
20002000-12-31	Operating cash flow	-1125566	Operating Cash Flow: -1125566 Open source
20012001-12-31	Operating cash flow	-2506042	Operating Cash Flow: -2506042 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.6M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	-178017	Operating Cash Flow: -164024 Open source Capital Expenditure: 13993 Open source
19971997-12-31	Free cash flow	-494208	Operating Cash Flow: -488451 Open source Capital Expenditure: 5757 Open source
19981998-12-31	Free cash flow	-466644	Operating Cash Flow: -454247 Open source Capital Expenditure: 12397 Open source
19991999-12-31	Free cash flow	-631418	Operating Cash Flow: -550241 Open source Capital Expenditure: 81177 Open source
20002000-12-31	Free cash flow	-1371996	Operating Cash Flow: -1125566 Open source Capital Expenditure: 246430 Open source
20012001-12-31	Free cash flow	-2641060	Operating Cash Flow: -2506042 Open source Capital Expenditure: 135018 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

13.7% 2001

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	No source recorded
19971997-12-31	Liabilities / assets	Not reported	Total Liabilities: 1305798 Open source
19981998-12-31	Liabilities / assets	Not reported	Total Liabilities: 1868739 Open source
19991999-12-31	Liabilities / assets	427.8%	Total Liabilities: 2365231 Open source Total Assets: 552819 Open source
20002000-12-31	Liabilities / assets	35.2%	Total Liabilities: 1033256 Open source Total Assets: 2934903 Open source
20012001-12-31	Liabilities / assets	13.7%	Total Liabilities: 497337 Open source Total Assets: 3626814 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.63× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Current assets / current liabilities	Not reported	No source recorded
19971997-12-31	Current assets / current liabilities	0.24×	Current Assets: 48115 Open source Current Liabilities: 196437 Open source
19981998-12-31	Current assets / current liabilities	0.05×	Current Assets: 22125 Open source Current Liabilities: 434793 Open source
19991999-12-31	Current assets / current liabilities	0.08×	Current Assets: 55216 Open source Current Liabilities: 658135 Open source
20002000-12-31	Current assets / current liabilities	2.29×	Current Assets: 2210631 Open source Current Liabilities: 965032 Open source
20012001-12-31	Current assets / current liabilities	6.63×	Current Assets: 2826767 Open source Current Liabilities: 426300 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	−USD 553,639 Exact value Exact value: -553639 USD 1996-01-01 – 1996-12-31: -553639 USD Inspect Net Income Open source Share or cite Citation for Net Income · IXION BIOTECHNOLOGY INC · 1996-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Net Income: -553639 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -553639 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-98-000004.txt#2589 The citation records this snapshot. The page link may show a newer release later.	−USD 164,024 Exact value Exact value: -164024 USD 1996-01-01 – 1996-12-31: -164024 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IXION BIOTECHNOLOGY INC · 1996-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Operating Cash Flow: -164024 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -164024 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-98-000004.txt#2609 The citation records this snapshot. The page link may show a newer release later.	USD 13,993 Exact value Exact value: 13993 USD 1996-01-01 – 1996-12-31: 13993 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IXION BIOTECHNOLOGY INC · 1996-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Capital Expenditure: 13993 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13993 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-98-000004.txt#2612 The citation records this snapshot. The page link may show a newer release later.	−USD 178,017 Calculation and evidence -164024 − 13993 USD Exact free cash flow: -178017 USD 1996-01-01 – 1996-12-31: -164024 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 13993 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IXION BIOTECHNOLOGY INC · 1996-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Free cash flow: -178017 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -164024 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-98-000004.txt#2609 Input fundies:CapitalExpenditure: 13993 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-98-000004.txt#2612 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 781,954 Exact value Exact value: -781954 USD 1997-01-01 – 1997-12-31: -781954 USD Inspect Net Income Open source Share or cite Citation for Net Income · IXION BIOTECHNOLOGY INC · 1997-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Net Income: -781954 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -781954 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-99-000006.txt#2702 The citation records this snapshot. The page link may show a newer release later.	−USD 488,451 Exact value Exact value: -488451 USD 1997-01-01 – 1997-12-31: -488451 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IXION BIOTECHNOLOGY INC · 1997-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Operating Cash Flow: -488451 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -488451 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-99-000006.txt#2730 The citation records this snapshot. The page link may show a newer release later.	USD 5,757 Exact value Exact value: 5757 USD 1997-01-01 – 1997-12-31: 5757 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IXION BIOTECHNOLOGY INC · 1997-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Capital Expenditure: 5757 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5757 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-99-000006.txt#2733 The citation records this snapshot. The page link may show a newer release later.	−USD 494,208 Calculation and evidence -488451 − 5757 USD Exact free cash flow: -494208 USD 1997-01-01 – 1997-12-31: -488451 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 5757 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IXION BIOTECHNOLOGY INC · 1997-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Free cash flow: -494208 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -488451 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-99-000006.txt#2730 Input fundies:CapitalExpenditure: 5757 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-99-000006.txt#2733 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 914,239 Exact value Exact value: -914239 USD 1998-01-01 – 1998-12-31: -914239 USD Inspect Net Income Open source Share or cite Citation for Net Income · IXION BIOTECHNOLOGY INC · 1998-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Net Income: -914239 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -914239 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2659 The citation records this snapshot. The page link may show a newer release later.	−USD 454,247 Exact value Exact value: -454247 USD 1998-01-01 – 1998-12-31: -454247 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IXION BIOTECHNOLOGY INC · 1998-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Operating Cash Flow: -454247 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -454247 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2680 The citation records this snapshot. The page link may show a newer release later.	USD 12,397 Exact value Exact value: 12397 USD 1998-01-01 – 1998-12-31: 12397 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IXION BIOTECHNOLOGY INC · 1998-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Capital Expenditure: 12397 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12397 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2683 The citation records this snapshot. The page link may show a newer release later.	−USD 466,644 Calculation and evidence -454247 − 12397 USD Exact free cash flow: -466644 USD 1998-01-01 – 1998-12-31: -454247 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 12397 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IXION BIOTECHNOLOGY INC · 1998-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Free cash flow: -466644 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -454247 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2680 Input fundies:CapitalExpenditure: 12397 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2683 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 1.13 million Exact value Exact value: -1125790 USD 1999-01-01 – 1999-12-31: -1125790 USD Inspect Net Income Open source Share or cite Citation for Net Income · IXION BIOTECHNOLOGY INC · 1999-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Net Income: -1125790 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1125790 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2659 The citation records this snapshot. The page link may show a newer release later.	−USD 550,241 Exact value Exact value: -550241 USD 1999-01-01 – 1999-12-31: -550241 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IXION BIOTECHNOLOGY INC · 1999-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Operating Cash Flow: -550241 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -550241 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2680 The citation records this snapshot. The page link may show a newer release later.	USD 81,177 Exact value Exact value: 81177 USD 1999-01-01 – 1999-12-31: 81177 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IXION BIOTECHNOLOGY INC · 1999-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Capital Expenditure: 81177 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 81177 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2683 The citation records this snapshot. The page link may show a newer release later.	−USD 631,418 Calculation and evidence -550241 − 81177 USD Exact free cash flow: -631418 USD 1999-01-01 – 1999-12-31: -550241 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 81177 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IXION BIOTECHNOLOGY INC · 1999-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Free cash flow: -631418 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -550241 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2680 Input fundies:CapitalExpenditure: 81177 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-00-000002.txt#2683 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 1.45 million Exact value Exact value: -1447347 USD 2000-01-01 – 2000-12-31: -1447347 USD Inspect Net Income Open source Share or cite Citation for Net Income · IXION BIOTECHNOLOGY INC · 2000-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Net Income: -1447347 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1447347 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2392 The citation records this snapshot. The page link may show a newer release later.	−USD 1.13 million Exact value Exact value: -1125566 USD 2000-01-01 – 2000-12-31: -1125566 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IXION BIOTECHNOLOGY INC · 2000-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Operating Cash Flow: -1125566 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1125566 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2410 The citation records this snapshot. The page link may show a newer release later.	USD 246,430 Exact value Exact value: 246430 USD 2000-01-01 – 2000-12-31: 246430 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IXION BIOTECHNOLOGY INC · 2000-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Capital Expenditure: 246430 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 246430 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2414 The citation records this snapshot. The page link may show a newer release later.	−USD 1.37 million Calculation and evidence -1125566 − 246430 USD Exact free cash flow: -1371996 USD 2000-01-01 – 2000-12-31: -1125566 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 246430 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IXION BIOTECHNOLOGY INC · 2000-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Free cash flow: -1371996 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1125566 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2410 Input fundies:CapitalExpenditure: 246430 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2414 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 2.99 million Exact value Exact value: -2987502 USD 2001-01-01 – 2001-12-31: -2987502 USD Inspect Net Income Open source Share or cite Citation for Net Income · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Net Income: -2987502 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2987502 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2392 The citation records this snapshot. The page link may show a newer release later.	−USD 2.51 million Exact value Exact value: -2506042 USD 2001-01-01 – 2001-12-31: -2506042 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Operating Cash Flow: -2506042 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2506042 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2410 The citation records this snapshot. The page link may show a newer release later.	USD 135,018 Exact value Exact value: 135018 USD 2001-01-01 – 2001-12-31: 135018 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Capital Expenditure: 135018 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 135018 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2414 The citation records this snapshot. The page link may show a newer release later.	−USD 2.64 million Calculation and evidence -2506042 − 135018 USD Exact free cash flow: -2641060 USD 2001-01-01 – 2001-12-31: -2506042 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 135018 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IXION BIOTECHNOLOGY INC · 2001-12-31 IXION BIOTECHNOLOGY INC (edgar:943403) Free cash flow: -2641060 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T20:27:28Z Snapshot: 377b72e313240ba6cd97d83f6d49ce016d4f496ed9093f7c60ad48e19484cd43 Dimensions: Consolidated View: https://fundies.io/companies/edgar/943403?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2506042 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2410 Input fundies:CapitalExpenditure: 135018 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943403/0000943403-02-000002.txt#2414 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0000943403, 943403, edgar:943403

IXION BIOTECHNOLOGY INC

Latest quarter

Revenue

Net margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation